基本信息
浏览量:71
职业迁徙
个人简介
Clive is the author of over 250 refereed international journal articles, textbook chapters and conference papers and over 100 major project reports to industry. He has supervised more than 35 PhD, 10 MSc and 30 Honours students and has taken a leadership role in a number of major collaborative projects in association with national and international industries, the ARC, and University researchers from Australia and overseas. Prof Prestidge has attracted competitive research grants worth more than $15M from government and industry sources.
Clive was the founder of Ceridia Pty Ltd, a clinical stage biopharmaceutical company established to commercial the the Lipoceramic drug delivery technology he invented.
The Prestidge research group is focused on Drug delivery, Nanomedicine and BioPharmaceutical Engineering. Its Primary Mission is to: (1) Engineer novel particle based biomaterials with specific biological activity and their application to solve biopharmaceutical challenges. (2) Determine mechanisms for bioactivity through advanced biophysical analysis (3) Develop drug delivery solutions to address unmet clinical needs. Some of our Grand Challenges are to: (1) Deliver Challenging Therapeutic Molecules – For Better Medicines (2) Eradicate Bacterial Biofilms (3) Optimise Biotech and Pharmaceutical Processing and Manufacture
研究兴趣
论文共 318 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Clinical & translational immunologyno. 2 (2024): e1492-e1492
Anam Ahsan,Nicky Thomas,Timothy J Barnes,Santhni Subramaniam, Thou Chen Loh,Paul Joyce,Clive A Prestidge
Pharmaceuticsno. 3 (2024): 396
Pharmaceuticsno. 2 (2024): 209
Juan Aparicio-Blanco, Nikhar Vishwakarma,Claus-Michael Lehr,Clive A. Prestidge,Nicky Thomas, Richard J. Roberts,Chelsea R. Thorn,Ana Melero
Foods (Basel, Switzerland)no. 7 (2024): 1039
Tahlia R. Meola, Aurelia Elz,Anthony Wignall, Kara Paxton, Alexander Hunter, Amin Ariaee,Srinivas Kamath,Stephanie E. Reuter,Clive A. Prestidge,Paul Joyce
Advanced Functional Materials (2024)
ACS INFECTIOUS DISEASESno. 2 (2024): 337-349
Expert opinion on drug delivery (2023)
引用0浏览0WOS引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn